Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.310
-0.300 (-8.31%)
At close: Oct 30, 2026, 4:00 PM EDT
3.396
+0.086 (2.60%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $12.63 million as of October 30, 2026. It is the 40,015th most valuable company in the world and the 5,452nd biggest in the United States. Its market cap has increased by 557.94% in one year.
Market Cap
12.63M
Enterprise Value
5.18M
1-Year Change
557.94%
Global Rank
Country Rank
#5,452 United States
Category
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $12.63M, a decrease of -96.10%. That is a compound annual growth rate of -48.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 12.63M | 795.17% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 14.23M |
| Dyadic International | 13.77M |
| Allarity Therapeutics | 13.75M |
| Daré Bioscience | 13.47M |
| BioCardia | 13.37M |
| Adial Pharmaceuticals | 13.26M |
| Cerenome | 13.13M |
| TScan Therapeutics | 12.97M |